Børre Fevang

Author information from the last article

Seksjon for klinisk immunologi og infeksjonssykdommer

Oslo universitetssykehus, Rikshospitalet

Forfatterbidrag: idé, datainnsamling, analyse og tolking av data, litteratursøk, utarbeiding og godkjenning av manuskriptet.

Børre Fevang er spesialist i indremedisin og i infeksjonssykdommer og er overlege. Han leder Norsk forening for infeksjonsmedisins ekspertgruppe for behandling av covid-19.

Articles by Børre Fevang

COVID-19 patients treated with convalescent plasma

Lise Sofie Haug Nissen-Meyer,
Magnhild Eide Macpherson,
Linda Gail Skeie,
Marte Hvalryg,
Abid Hussain Llohn,
Tine Torsvik Steinsvåg,
Mona Høysæter Fenstad,
Anders Tveita,
Einar K. Kristoffersen,
Tatjana Sundic,
Fridtjof Lund-Johansen,
John Torgils Vaage,
Øystein Flesland,
Anne Ma Dyrhol-Riise,
Jan Cato Holter,
Tor Audun Hervig,
Børre Fevang

03.08.2023: COVID-19 convalescent plasma (NORPLASMA) (1) first became available to Norwegian patients in the spring of 2020. The Norwegian Directorate of Health recommended use of the product in patients who were at risk of developing a severe/life-threatening course of COVID-19, where the attending doctor...

COVID-19 convalescent plasma from Norwegian blood donors

Lise Sofie Haug Nissen-Meyer,
Tor Hervig,
Børre Fevang,
Gunnstein Norheim,
Anne-Marte Bakken Kran,
John Torgils Vaage,
Øystein Flesland

14.06.2022: The collection and use of convalescent plasma to treat COVID-19 has taught us important lessons about the organisation, testing and selection of blood donors and patients. This is knowledge that can be used in the next pandemic. Convalescent plasma is plasma taken from survivors of a severe...